This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Potential Association Between Risperidone and Cerebrovascular Events

William V. Bobo, MD; Kenneth F. More, MD

Published: June 1, 2003

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We read with interest the recently published discussion concerning the primary care setting.1 The role of resperidone and olanzapine in managing the adverse behavioral manifestations of dementia, including agression and other behavioral dyscontrol problems, was of particular interest. We were appreciative of the emphasis placed upon judicious use of low doses of these medications and the emergence of significant side effects such as falls and somnolence at very low doses of resperidone in particular.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 5

Quick Links: Neurologic and Neurocognitive , Stroke


Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...